Biotech company Mogu raises 11 million euros in funding

Italian biotech company Mogu Srl, also known as Sqim, which specialises in biofabricated materials made from pure mycelium, the root structure of mushrooms, has raised 11 million euros in Series A funding to allow for further industrial scaling of its innovative technologies and to develop its Ephea and Mogu product lines.


OR CONTINUE WITH
Biotech
Ephea
Kering Ventures
Mogu
Mycelium
Sqim